ARCHIVES

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

New ACS Awards Total $18.4 Million

February 23, 1979

Frederick RFP Available Oct. 22; Three Four May Challenge L-B

August 27, 1976

In Brief: David Chambers named deputy director for implementation science at NCI DCCPS

December 5, 2014

Chemical Society Designates Taxol, Camptothecin Discoveries Historic

April 25, 2003

MD Anderson Expands Reach Into Florida, Ohio

September 26, 2014

Cancer Centers Win Majority Of Grants In Recent NCI RFAs, Klausner Tells AACI.

October 6, 2000